We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

2 hedge funds and large institutions have $442 invested in Avadel Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 202 closing their positions.

New
Increased
Maintained
Reduced
Closed

75.53% less ownership

Funds ownership: 75.53% → 0% (-76%)

99% less funds holding

Funds holding: 207 → 2 (-205)

100% less funds holding in top 10

Funds holding in top 10: 8 → 0 (-8)

100% less capital invested

Capital invested by funds: $1.6B → $442 (-$1.6B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 202

Holders
2
Holders Change
-205
Holders Change %
-99.03%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
202
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$152M
2
GJL
Gendell Jeffrey L
-$103M
3
WAM
Weiss Asset Management
Massachusetts
-$97.3M
4
TAL
TIG Advisors LLC
New York
-$83.2M
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$64.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
126
MAI Capital Management
Ohio
– -$517K -23,968 Closed
ET
127
Entropy Technologies
New York
– -$516K -23,952 Closed
AWA
128
Aaron Wealth Advisors
Illinois
– -$507K -23,543 Closed
TRCT
129
Tower Research Capital (TRC)
New York
– -$499K -23,160 Closed
Citigroup
130
Citigroup
New York
– -$487K -22,579 Closed
XT
131
XTX Topco
Cayman Islands
– -$475K -22,039 Closed
Creative Planning
132
Creative Planning
Kansas
– -$434K -20,154 Closed
AQR Capital Management
133
AQR Capital Management
Connecticut
– -$430K -19,963 Closed
US Bancorp
134
US Bancorp
Minnesota
– -$408K -18,925 Closed
KK
135
KLP Kapitalforvaltning
Norway
– -$401K -18,600 Closed
GCL
136
Glazer Capital LLC
New York
– -$388K -18,000 Closed
LPL Financial
137
LPL Financial
California
– -$386K -17,915 Closed
Osaic Holdings
138
Osaic Holdings
Arizona
– -$363K -16,829 Closed
Marshall Wace
139
Marshall Wace
United Kingdom
– -$360K -16,686 Closed
PCM
140
Polymer Capital Management
New York
– -$354K -16,441 Closed
VEA
141
Virtus ETF Advisers
New York
– -$353K -16,385 Closed
VOYA Investment Management
142
VOYA Investment Management
Georgia
– -$348K -16,140 Closed
HighTower Advisors
143
HighTower Advisors
Illinois
– -$328K -15,209 Closed
KF
144
Krilogy Financial
Missouri
– -$325K -15,082 Closed
LIP
145
Lighthouse Investment Partners
Florida
– -$317K -14,692 Closed
QOP
146
Quinn Opportunity Partners
Virginia
– -$302K -14,028 Closed
JG
147
Jain Global
New York
– -$301K -13,976 Closed
SPS
148
Susquehanna Portfolio Strategies
Pennsylvania
– -$292K -13,552 Closed
PA
149
Profund Advisors
Maryland
– -$288K -13,354 Closed
Teacher Retirement System of Texas
150
Teacher Retirement System of Texas
Texas
– -$279K -12,963 Closed
4 5
6
7 8

AVDL Hedge Fund Activity: Q1 2026 in Review

2 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2026, worth a combined $442 — down 100% from $1.6B a quarter earlier.

Sellers outnumbered buyers: 202 funds closed out of AVDL and 0 opened new positions — a net loss of 202 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $152M sold.

  • 2 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2026, down from 207 in Q4 2025.
  • Funds reported $442 of Avadel Pharmaceuticals stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Avadel Pharmaceuticals positions in Q1 2026 and 202 closed out, a net change of -202 holders.
  • The largest Avadel Pharmaceuticals seller in Q1 2026 was BlackRock, an estimated $152M sold.

Based on aggregated 13F filings for Q1 2026.